Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.
2.

Risk of cardiotoxicity induced by adjuvant anthracycline-based chemotherapy and radiotherapy in young and old Asian women with breast cancer.

Lee CH, Zhang JF, Yuan KS, Wu ATH, Wu SY.

Strahlenther Onkol. 2019 Jan 28. doi: 10.1007/s00066-019-01428-7. [Epub ahead of print]

PMID:
30690687
3.

Predicting 90-Day Mortality in Locoregionally Advanced Head and Neck Squamous Cell Carcinoma after Curative Surgery.

Qin L, Chen TM, Kao YW, Lin KC, Yuan KS, Wu ATH, Shia BC, Wu SY.

Cancers (Basel). 2018 Oct 22;10(10). pii: E392. doi: 10.3390/cancers10100392.

4.

Comorbidity profiles among patients with recurrent aphthous stomatitis: A case-control study.

Lin KC, Tsai LL, Ko EC, Sheng-Po Yuan K, Wu SY.

J Formos Med Assoc. 2019 Mar;118(3):664-670. doi: 10.1016/j.jfma.2018.10.002. Epub 2018 Oct 19.

5.

Fucoidan Inhibits Radiation-Induced Pneumonitis and Lung Fibrosis by Reducing Inflammatory Cytokine Expression in Lung Tissues.

Yu HH, Chengchuan Ko E, Chang CL, Yuan KS, Wu ATH, Shan YS, Wu SY.

Mar Drugs. 2018 Oct 19;16(10). pii: E392. doi: 10.3390/md16100392.

6.

Combination of recurrent oral aphthae and dry eye syndrome may constitute an independent risk factor for oral cavity cancer in elderly women.

Qin L, Kao YW, Lin YL, Peng BY, Deng WP, Chen TM, Lin KC, Yuan KS, Wu AT, Shia BC, Wu SY.

Cancer Manag Res. 2018 Sep 5;10:3273-3281. doi: 10.2147/CMAR.S168477. eCollection 2018.

7.

Intensity-modulated radiotherapy with systemic chemotherapy improves survival in patients with nonmetastatic unresectable pancreatic adenocarcinoma: A propensity score-matched, nationwide, population-based cohort study.

Lin YK, Hsieh MC, Chang CL, Chow JM, Yuan KS, Wu ATH, Wu SY.

Radiother Oncol. 2018 Nov;129(2):326-332. doi: 10.1016/j.radonc.2018.07.012. Epub 2018 Aug 3.

PMID:
30082144
8.

Recurrent aphthous stomatitis may be a precursor or risk factor for specific cancers: A case-control frequency-matched study.

Qin L, Kao YW, Lin YL, Peng BY, Deng WP, Chen TM, Lin KC, Yuan KS, Wu ATH, Shia BC, Wu SY.

Cancer Med. 2018 Aug;7(8):4104-4114. doi: 10.1002/cam4.1685. Epub 2018 Jul 15.

9.

Efficacy of thoracic radiotherapy in patients with stage IIIB-IV epidermal growth factor receptor-mutant lung adenocarcinomas who received and responded to tyrosine kinase inhibitor treatment.

Yen YC, Hsu HL, Chang JH, Lin WC, Chang YC, Chang CL, Chow JM, Yuan KS, Wu ATH, Wu SY.

Radiother Oncol. 2018 Oct;129(1):52-60. doi: 10.1016/j.radonc.2018.03.007. Epub 2018 Apr 24.

PMID:
29703499
10.

Treatment of advanced nasopharyngeal cancer using low- or high-dose concurrent chemoradiotherapy with intensity-modulated radiotherapy: A propensity score-matched, nationwide, population-based cohort study.

Chen TM, Lin KC, Yuan KS, Chang CL, Chow JM, Wu SY.

Radiother Oncol. 2018 Oct;129(1):23-29. doi: 10.1016/j.radonc.2017.12.004. Epub 2017 Dec 22.

PMID:
29277447
11.

Dose escalation intensity-modulated radiotherapy-based concurrent chemoradiotherapy is effective for advanced-stage thoracic esophageal squamous cell carcinoma.

Chang CL, Tsai HC, Lin WC, Chang JH, Hsu HL, Chow JM, Yuan KS, Wu ATH, Wu SY.

Radiother Oncol. 2017 Oct;125(1):73-79. doi: 10.1016/j.radonc.2017.08.025. Epub 2017 Sep 17.

PMID:
28923576
12.

Locoregionally recurrent head and neck squamous cell carcinoma: incidence, survival, prognostic factors, and treatment outcomes.

Chang JH, Wu CC, Yuan KS, Wu ATH, Wu SY.

Oncotarget. 2017 Mar 17;8(33):55600-55612. doi: 10.18632/oncotarget.16340. eCollection 2017 Aug 15.

13.

Value and application of trimodality therapy or definitive concurrent chemoradiotherapy in thoracic esophageal squamous cell carcinoma.

Lin WC, Ding YF, Hsu HL, Chang JH, Yuan KS, Wu ATH, Chow JM, Chang CL, Chen SU, Wu SY.

Cancer. 2017 Oct 15;123(20):3904-3915. doi: 10.1002/cncr.30823. Epub 2017 Jun 13.

14.

Cyproheptadine use in hepatocellular carcinoma.

Hsieh MC, Lee WH, Wu AT, Chow JM, Chang CL, Yuan KS, Wu SY.

Am J Cancer Res. 2017 Mar 1;7(3):584-602. eCollection 2017.

15.

High-dose or low-dose cisplatin concurrent with radiotherapy in locally advanced head and neck squamous cell cancer.

Chang CL, Yuan KS, Wu SY.

Head Neck. 2017 Jul;39(7):1364-1370. doi: 10.1002/hed.24763. Epub 2017 Mar 28.

PMID:
28370614
16.

Effectiveness of esophagectomy in patients with thoracic esophageal squamous cell carcinoma receiving definitive radiotherapy or concurrent chemoradiotherapy through intensity-modulated radiation therapy techniques.

Yen YC, Chang JH, Lin WC, Chiou JF, Chang YC, Chang CL, Hsu HL, Chow JM, Yuan KS, Wu ATH, Wu SY.

Cancer. 2017 Jun 1;123(11):2043-2053. doi: 10.1002/cncr.30565. Epub 2017 Feb 2.

17.
18.

Survival prognostic factors for metachronous second primary head and neck squamous cell carcinoma.

Chen JH, Yen YC, Chen TM, Yuan KS, Lee FP, Lin KC, Lai MT, Wu CC, Chang CL, Wu SY.

Cancer Med. 2017 Jan;6(1):142-153. doi: 10.1002/cam4.976. Epub 2016 Dec 17.

19.

Efficacy of postoperative radiotherapy in patients with pathological stage N2 epidermal growth factor receptor wild type adenocarcinoma and squamous cell carcinoma lung cancer.

Lin YK, Hsu HL, Lin WC, Chang JH, Chang YC, Chang CL, Yuan KS, Wu ATH, Wu SY.

Oncotarget. 2017 May 23;8(21):35280-35288. doi: 10.18632/oncotarget.13257.

20.

Statins dose-dependently exert a significant chemopreventive effect on colon cancer in patients with chronic obstructive pulmonary disease: A population-based cohort study.

Liu JC, Hao WR, Hsu YP, Sung LC, Kao PF, Lin CF, Wu AT, Yuan KS, Wu SY.

Oncotarget. 2016 Oct 4;7(40):65270-65283. doi: 10.18632/oncotarget.11263.

Supplemental Content

Loading ...
Support Center